A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.
Torigen vaccinates $3.1m series A Building on research by a former University of Minnesota professor, Torigen Pharmaceuticals has begun in-veterinary testing of its immunooncology vaccine for companion animals. Recida rolls out from Frazier Healthcare Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.